INCATE

INCATE - INCubator for Antibacterial Therapies Europe – is a partnership which brings together translational and basic research, industry, experienced entrepreneurs and investors from across Europe and beyond. Our focus is on the development of new therapies, diagnostics and interventions that help reduce the prevalence and impact of AMR. INCATE helps early-stage innovators to accelerate their Antimicrobial Resistance (AMR) initiatives by providing advice on any R&D or funding matter, access to our community and funding. When ready, innovators are encouraged to apply for Stage I for more detailed feedback from Industry partners and funding. Stage II projects receive a superior funding and further support to build a company ready for the next stage of investment.
Applications are accepted on a rolling basis. Get in touch with our scouting team or reach out to us via email at [email protected] to find out how INCATE can help your AMR initiative.